Literature DB >> 27190911

Is Reactive Dengue NS1Antigen Test a Warning Call for Hospital Admissions?

Sriram Pothapregada1, Banupriya Kamalakannan2, Mahalakshmy Thulasingam3, Srinivasan Sampath4.   

Abstract

INTRODUCTION: Dengue fever is a major public health problem worldwide. The 2011 revised World Health Organization (WHO) guidelines have emphasized on early diagnosis and intervention to reduce the case fatality rate due to dengue fever. Rapid diagnostic tests like NS1 antigen assays have improved the detection of cases in early clinical phase of illness but its role as a predictor of severe dengue infection is not very clear. AIM: To evaluate the utility of NS1 Ag assay as an early diagnostic marker and predictor of severe dengue infection.
MATERIALS AND METHODS: All children (0-12 years of age) diagnosed and confirmed with dengue fever at a tertiary care hospital in Puducherry between 01(st) August 2012 and 31(st) July 2015 were reviewed retrospectively from hospital case records as per the revised WHO guidelines for dengue fever. The diagnosis was confirmed by NS1antigen-based ELISA test or dengue serology for IgM and IgG antibodies and the data were analysed using SPSS 16.0 statistical software. After collecting all the data, all the variables were summarised by descriptive statistics. Categorical variables were expressed as frequencies and percentages, and then analysed by the χ(2) test or fishers exact test, where appropriate. Significance was taken at p-value< 0.05.
RESULTS: Among the 261 confirmed cases of dengue fever non-severe dengue and severe dengue infection was seen in 60.9% and 39.1% respectively. The mean age of presentation was 6.9 years and M:F ratio was 1.2:1. NS1 Ag was positive in 217 cases (83.1%) and among them non-severe dengue and severe dengue was seen in 65.9% and 34.1% cases respectively. A total of 44 cases (16.9%) were negative for NS1 Ag assay and positive for IgM MAC ELISA and among them 16 children (36.4%) had non-severe dengue infection where as 28 children (63.6%) had severe dengue infection. Secondary infection with (MAC-ELISA IgG) was seen in 17 cases (6.5%). NS1Ag assay was predominantly positive in acute phase sera, where as IgM/IgG MAC ELISA was predominantly positive in convalescent phase sera. There were six deaths (2.3%) and the common causes of poor outcome were multiorgan failure, encephalopathy and refractory shock.
CONCLUSION: NS1 Ag assay is a useful early diagnostic marker for dengue fever but cannot be used as an early predictor of severe dengue infection. The criteria for admission in hospitals of cases of dengue fever should be based on clinical warning signs rather than positive NS1 Antigen test.

Entities:  

Keywords:  ELISA; Early diagnosis; Severe dengue; World health organization

Year:  2016        PMID: 27190911      PMCID: PMC4866209          DOI: 10.7860/JCDR/2016/16178.7636

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  18 in total

Review 1.  Dengue: an update.

Authors:  María G Guzmán; Gustavo Kourí
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

2.  The use of dengue nonstructural protein 1 antigen for the early diagnosis during the febrile stage in patients with dengue infection.

Authors:  Ampaiwan Chuansumrit; Wathanee Chaiyaratana; Viroj Pongthanapisith; Kanchana Tangnararatchakit; Sarapee Lertwongrath; Sutee Yoksan
Journal:  Pediatr Infect Dis J       Date:  2008-01       Impact factor: 2.129

3.  Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: Implications for early diagnosis and serotyping of dengue virus infections.

Authors:  Hua Xu; Biao Di; Yu-xian Pan; Li-wen Qiu; Ya-di Wang; Wei Hao; Li-juan He; Kwok-yung Yuen; Xiao-yan Che
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

4.  Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum.

Authors:  Philippe Dussart; Bhety Labeau; Gisèle Lagathu; Philippe Louis; Marcio R T Nunes; Sueli G Rodrigues; Cécile Storck-Herrmann; Raymond Cesaire; Jacques Morvan; Marie Flamand; Laurence Baril
Journal:  Clin Vaccine Immunol       Date:  2006-09-20

5.  Simultaneous Detection of Dengue NS1 Antigen, IgM plus IgG and Platelet Enumeration during an Outbreak.

Authors:  Subhash C Arya; Nirmala Agarwal; Satibh C Parikh; Shekhar Agarwal
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

6.  Dengue NS1 antigen detection: a useful tool in early diagnosis of dengue virus infection.

Authors:  S Datta; C Wattal
Journal:  Indian J Med Microbiol       Date:  2010 Apr-Jun       Impact factor: 0.985

7.  Comparison of two commercially available dengue virus (DENV) NS1 capture enzyme-linked immunosorbent assays using a single clinical sample for diagnosis of acute DENV infection.

Authors:  Kovi Bessoff; Mark Delorey; Wellington Sun; Elizabeth Hunsperger
Journal:  Clin Vaccine Immunol       Date:  2008-08-06

8.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.

Authors:  Daniel H Libraty; Paul R Young; Darren Pickering; Timothy P Endy; Siripen Kalayanarooj; Sharone Green; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-09-16       Impact factor: 5.226

9.  Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay.

Authors:  E A Henchal; J M McCown; M C Seguin; M K Gentry; W E Brandt
Journal:  Am J Trop Med Hyg       Date:  1983-01       Impact factor: 2.345

10.  The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection.

Authors:  Leera Kittigul; Piyamard Pitakarnjanakul; Dusit Sujirarat; Kanokrat Siripanichgon
Journal:  J Clin Virol       Date:  2007-05-15       Impact factor: 3.168

View more
  1 in total

1.  Hospital-based Surveillance: Accuracy, Adequacy, and Timeliness of Dengue Case Report in Bandung, West Java, Indonesia of 2015.

Authors:  Riyadi Adrizain; Djatnika Setiabudi; Alex Chairulfatah
Journal:  J Glob Infect Dis       Date:  2018 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.